Mutual of America Capital Management LLC Sells 267 Shares of STERIS plc (NYSE:STE)

Mutual of America Capital Management LLC lowered its position in STERIS plc (NYSE:STE) by 2.0% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 12,984 shares of the medical equipment provider’s stock after selling 267 shares during the quarter. Mutual of America Capital Management LLC’s holdings in STERIS were worth $2,919,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. First Personal Financial Services bought a new stake in shares of STERIS in the 1st quarter worth approximately $25,000. Quent Capital LLC lifted its position in shares of STERIS by 112.7% during the 1st quarter. Quent Capital LLC now owns 134 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 71 shares during the period. VisionPoint Advisory Group LLC bought a new position in shares of STERIS during the 4th quarter worth approximately $34,000. Pingora Partners LLC bought a new position in shares of STERIS during the 4th quarter worth approximately $37,000. Finally, Glassman Wealth Services bought a new position in shares of STERIS during the 4th quarter worth approximately $38,000. Institutional investors own 94.69% of the company’s stock.

STERIS Stock Up 1.8 %

NYSE STE opened at $221.72 on Friday. The stock has a fifty day moving average of $222.80 and a 200-day moving average of $221.23. The stock has a market capitalization of $21.92 billion, a P/E ratio of 58.04 and a beta of 0.83. STERIS plc has a 52 week low of $195.47 and a 52 week high of $254.00. The company has a debt-to-equity ratio of 0.49, a quick ratio of 2.36 and a current ratio of 3.08.

STERIS (NYSE:STE) last released its earnings results on Wednesday, May 8th. The medical equipment provider reported $2.58 EPS for the quarter, beating the consensus estimate of $2.41 by $0.17. STERIS had a return on equity of 13.73% and a net margin of 6.95%. The company had revenue of $1.42 billion during the quarter, compared to analysts’ expectations of $1.41 billion. During the same period last year, the firm earned $2.30 EPS. The business’s revenue for the quarter was up 10.8% on a year-over-year basis. On average, equities research analysts forecast that STERIS plc will post 9.24 EPS for the current year.

STERIS Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, June 26th. Investors of record on Wednesday, June 12th were paid a dividend of $0.52 per share. The ex-dividend date was Wednesday, June 12th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 0.94%. STERIS’s dividend payout ratio (DPR) is presently 54.45%.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on STE shares. JMP Securities restated a “market outperform” rating and set a $265.00 target price on shares of STERIS in a research report on Thursday, May 9th. Piper Sandler reiterated a “neutral” rating and issued a $225.00 price objective (up previously from $220.00) on shares of STERIS in a research report on Friday, May 10th. StockNews.com upgraded STERIS from a “hold” rating to a “buy” rating in a research report on Saturday, June 15th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of STERIS in a research report on Friday, May 10th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, STERIS currently has a consensus rating of “Moderate Buy” and a consensus target price of $241.60.

Insider Buying and Selling

In related news, VP Renato Tamaro sold 1,154 shares of STERIS stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $231.64, for a total transaction of $267,312.56. Following the completion of the sale, the vice president now directly owns 6,677 shares of the company’s stock, valued at $1,546,660.28. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other STERIS news, SVP Cary L. Majors sold 2,024 shares of STERIS stock in a transaction dated Monday, May 13th. The stock was sold at an average price of $232.13, for a total transaction of $469,831.12. Following the transaction, the senior vice president now directly owns 11,369 shares in the company, valued at $2,639,085.97. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, VP Renato Tamaro sold 1,154 shares of STERIS stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $231.64, for a total value of $267,312.56. Following the transaction, the vice president now owns 6,677 shares in the company, valued at $1,546,660.28. The disclosure for this sale can be found here. Insiders sold a total of 7,762 shares of company stock valued at $1,798,477 over the last three months. Company insiders own 1.14% of the company’s stock.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.